June 26, 2026
No Comments
AI-Powered Literature Monitoring for Pharmacovigilance
Automate literature monitoring across global and local sources, identify safety-relevant publications and adverse event/ICSR candidates earlier, and maintain audit-ready documentation for every search.
Global + local sources
AI-assisted screening
Audit-ready workflows
DrugCard Platform in Numbers
146+
Countries
Medical journals coverage
Medical journals coverage
2200+
Local journals
Continuously monitored
Continuously monitored
~2
Weeks
New country Easily Added
New country Easily Added
End-to-End Medical Literature Monitoring Services for Pharmacovigilance
DrugCard covers the full cycle of literature monitoring in pharmacovigilance — search strategies, screening, documentation — across global and local sources in one validated PV system.
Global Literature Monitoring
Your pharmacovigilance literature search runs on a schedule across widely used reference databases and other medical literature databases — Medline/PubMed and Excerpta Medica (Embase). Query multiple databases at once, once a week or more often, and review deduplicated search results in one queue.
Local Literature Monitoring
Access regional medical journals and non-indexed publications that global databases often miss. Automatic translation makes local sources easy to review alongside English-language scientific literature.
AI-Assisted Literature Screening
AI pre-assesses every publication for safety relevance, highlighting suspected adverse reactions and product mentions so your team can focus on what matters most.
A More Efficient Literature Screening Workflow
Traditional manual process
× Search multiple databases and local medical journals manually
× Read large volumes of low-relevance published articles
× Translate non-English scientific publications separately
× Document searches and decisions by hand
× Coordinate fragmented workflows across countries
With DrugCard
✓ Centralised global and local literature monitoring
✓ AI-assisted relevance pre-assessment
✓ Automatic translation and article summaries
✓ Built-in documentation and audit trail
✓ Standardised search strategies across projects and markets
Key Benefits of Our AI-Driven Literature Monitoring Platform
DrugCard unifies global and local publications into one consistent, standardized process. The same workflow, the same quality, and the same reliable automation — whether you track PubMed full texts or local non indexed journal sources.
Complete Global & Local Coverage
All medical sources in one platform — from global literature full-text monitoring to 146 countries and 2200+ local sources. Every client gets a tailored source list, country-specific recommendations, and fast addition of any journal without bureaucracy.
Higher Impact With the Same Team
Automation removes repetitive literature screening so your experts can focus on real PV work — signal detection, risk assessment, drug safety documentation, and scientific evaluation.
Zero Missed Publications, Zero Compliance Risk
The platform captures all published articles and scientific literature automatically — no human errors. All results are fully traceable so nothing is overlooked.
Full Visibility and Built-In Documentation
You see every task, action, and screening step in real time, eliminating blind spots. DrugCard automatically records all activities, providing complete traceability and ready-to-present audit evidence without manual paperwork.
Data Integrity and Security
Your PV data is protected by FDA 21 CFR Part 11–compliant records and signatures, plus a certificate of conformity for use in the EU, US, and CIS. Hosting on ISO/IEC 27001:2013 and SOC 2 Type II infrastructure ensures enterprise-grade security.
Always-On Access, Anywhere
As a SaaS solution, DrugCard ensures uninterrupted, 24/7 access on any device. Your work continues smoothly, even across teams, regions, and time zones.
Does this sound like a solution that could help your team right now?
We invite you to experience the benefits of DrugCard with a free 2-week trial.
How It Works
1. Create your project
Select countries, define your coverage (whether it’s global searches, or local publications), and identify the products you want to monitor.
2. Get instant results
The system processes sources immediately — no manual runs or waiting time for search results.
3. Stay updated automatically
Receive real-time notifications about new findings and weekly automated reports for full oversight.
Literature Monitoring Across Key Pharmacovigilance Activities
ICSR Detection From Medical Literature
Spot individual case safety reports in published articles and convert one into a case in a single click, inside the DrugCard adverse event database.
Safety Signal Detection and Surveillance
Continuous literature surveillance helps marketing authorisation holders maintain awareness of emerging drug safety issues and contextualise spontaneous reports.
Literature Support for Aggregate Reporting
Export documented search results and relevant references for PSURs, PBRERs and DSURs, with a full audit trail.
Comprehensive Feature Set for Literature Screening
AI Article Summaries
Artificial intelligence instantly generates summaries so you can understand the relevant articles’ content without reading the full text.
AI Pre-Assessment of Safety Relevance
Artificial intelligence identifies whether an article contains any safety-relevant references, safety signals, and prioritizes it.
One-Click Case Creation From Literature
Convert an article into an individual case safety report in a single click. Fully integrated with the DrugCard adverse event database.
Automatic Translation of Local Sources
Over 100 supported languages ensure that local literature is just as accessible as global literature — no external translation needed.
Validated, Audit-Ready Platform
Successfully tested through inspections and audits. Trusted for reliable, regulatory-ready performance.
Flexible Project Configuration
Configure literature search projects for any setup — multi-country, multi-client, diverse roles, source lists, and requirements.
Medical Literature Coverage
Global Medical Literature Sources
Monitor scientific and medical literature in widely used reference databases such as PubMed and Embase.
Local and Non-Indexed Literature Sources
2,200+ local medical journals in 146+ countries, including print-only and non-indexed journals.
Country-Specific Source Configuration
Any journal or country can be added, typically in about two weeks.
See How Pharmacovigilance Teams Use DrugCard
June 26, 2026
No Comments
June 26, 2026
No Comments
Why Leading Pharmacovigilance Teams Choose Us
Teams rely on us for dependable literature surveillance that saves time and supports safety work across all therapeutic areas.
Unmatched Expertise in Literature Screening
Experts in literature review, drug safety, and medicinal products' safety signals — delivering the accuracy your PV processes rely on.
Full Compliance with GVP & Data Security
The system includes all essential controls for GxP activity and good pharmacovigilance practice. You get comprehensive, structured results; role-based user access control; automatic aggregate reports, including search strategy documentation; and a complete audit trail. There’s no need to download or review files manually — the system handles it for you.
A Shift From Manual Reading to Automated Medical Literature
The problem with manual screening
Manual literature review consumes hours of repetitive literature surveillance and regulatory reporting, increases the risk of human error and burnout, and makes traceability difficult.
How DrugCard solves it
As the only SaaS tailored to your local and global literature search needs, we offer automated AI relevance checks, summaries, keyword highlighting, weekly reports, and real-time notifications plus continuously expanding coverage.
Have a question?
Just fill out the form and we will contact you within 60 min.
- Book a meeting for the demonstraion
- Anwers your additional questions
- Implenetation DrugCard to your pharmacovigilance system
- Tariff plans, pricing, addional features
